TCRX NASDAQ
TScan Therapeutics, Inc.
1W: -5.7%
1M: -15.9%
3M: -69.5%
YTD: -68.6%
1Y: -84.7%
3Y: -88.0%
5Y: -95.9%
$0.32
+0.00 (+0.94%)
Weekly Expected Move ±11.0%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
4 relationships4
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2021-12-02
Earliest Filing
2024-12-26
Latest Filing
partner: 3
investor: 1
Counterparties (Filed by TCRX)
4 relationshipsCompanies named in TCRX's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Lynx1 Capital Management LP | — | investor | Purchaser of pre-funded warrants in a registered direct offering. | 2024-12-26 | View |
| PPF OFF 828-830 Winter Street LLC | — | partner | Landlord for the lease of additional office space at 830 Winter Street, Waltham, Massachusetts. | 2024-11-01 | View |
| Amgen Inc. | AMGN | partner | Collaboration Agreement for target discovery in Crohn's disease with upfront payment and milestone payments. | 2023-05-09 | View |
| BXP Waltham Woods LLC | — | partner | Landlord in lease agreement for office and laboratory space. | 2021-12-02 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-30 | Officer/Director Change | View | |
| 2026-09-11 | Officer/Director Change | View | |
| 2026-09-02 | Exit/Disposal Costs; Delisting Notice; Officer/Director Change; Regulation FD; Other Events; Exhibit | View | |
| 2026-08-18 | Termination of Agreement | View | |
| 2026-08-12 | Earnings Release; Exhibits | View | |
| 2026-06-22 | Regulation FD; Other Events; Exhibits | View | |
| 2026-05-22 | Bylaws Amendment; Shareholder Vote; Exhibits | View | |
| 2026-05-06 | Earnings Release; Exhibits | View | |
| 2026-04-02 | Officer/Director Change | View | |
| 2026-03-04 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-01-12 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-11-26 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-11-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-11-03 | Costs Associated with Exit or Disposal Activities; Regulation FD Disclosure; Other Events; Financial | View | |
| 2025-09-09 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-08-20 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-08-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-07-02 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-05-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-03-05 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR